Aequs Limited (AEQUS)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Consolidated revenue grew 55% y-y to INR3,955 million; aerospace up 40%, consumer up 190%
- Aerospace segment EBITDA margin at 23% with 40% revenue growth in Q1 FY27
- Consumer segment EBITDA loss narrowed by INR112 million sequentially; on track for Q4 FY27 breakeven
- Order book crossed USD1 billion; signed 15-year contract for Airbus A320 wheels with Safran
- Capex guidance: INR660 Cr in FY27; Hosur integrated facility INR1,900 Cr over 10 years
- Finance cost reduced due to debt repayment; net working capital days improved to 125
- Consumer utilization at 22%, expected to reach 40-50% by Q4 FY27
- ROCE target steady at 18-22% for both segments; PAT breakeven expected by H1 FY28 for consumer
- No material impact from global tariff changes; demand driven by customer orders
- Management confident on execution and growth trajectory for FY27
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 AEQUS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add AEQUS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Aequs Limited
Important.
The summary above is generated automatically from Aequs Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.